Matinas BioPharma Holdings Inc (NYSE American:MTNB)
| 0.6821 Delayed Data As of May 13 |  +0.0115 / +1.71%Today’s Change | 0.49 Today|||52-Week Range 1.61 | -32.47% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 194.5K | 0.00 | 149.7K | 119.8K | |
| Depreciation And Amortization | 43.5K | 52.6K | 100.6K | 218.3K | ||
| Operating Expenses | Gross Income | -- | -52.6K | -- | -- | |
| General Expenses | 9.2M | 8.2M | 16.6M | 14.5M | ||
| Research And Development | 5.3M | 3.9M | 9.0M | 6.8M | ||
| Total Operating Expenses | 9.3M | 8.3M | 16.7M | 14.8M | ||
| Non-Operating Expenses | Operating Income | -9.1M | -8.3M | -16.5M | -14.6M | |
| Extraordinary Credit | 756.5K | 674.9K | 636.9K | 0.00 | ||
| Extraordinary Charge | -853.3K | 0.00 | 0.00 | 0.00 | ||
| Interest Expense On Debt | 885.00 | 16.5K | 0.00 | 0.00 | ||
| Other Expenses | 20.5K | 0.00 | 22.0K | 56.6K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -9.1M | -7.6M | -15.8M | -14.6M | |
| Income Taxes | 0.00 | 0.00 | -357.0K | -506.9K | ||
| Preferred Dividend | 0.00 | -4.4M | -608.3K | -905.0K | ||
| Net Income | -9.1M | -7.6M | -32.2M | -14.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 51.5M | 57.7M | 90.5M | 98.1M | |
| Shares To Calculate EPS Diluted | 51.5M | 57.7M | 90.5M | 98.1M | ||
| Earnings Per Share | EPS | -$0.18 | -$0.21 | -$0.36 | -$0.15 | |
| EPS Diluted | -$0.18 | -$0.21 | -$0.36 | -$0.15 | ||
